SeQuent® Please Neo

DEVICE2 trials

Sponsors

JW Medical Systems Ltd, Genoss Co., Ltd.

Conditions

Coronary Artery Disease

Unknown Phase

The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis

JW Medical Systems LtdCoronary Artery Disease

Start: 2020-12-17End: 2025-02-18Updated: 2023-11-18

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

CompletedNCT05096442

Genoss Co., Ltd.Coronary Artery Disease

Start: 2021-09-30End: 2023-11-21Updated: 2024-05-17

Related Papers

A Prospective Randomized Trial Comparing 2 Different Paclitaxel-Coated Balloons in De Novo Coronary Artery Disease.

2025-01-07

Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial

EuroIntervention2024-06-2617 citations